GlobalData Healthcare

All articles by GlobalData Healthcare

1. Clinical trials landscape of checkpoint modulator trials

   GlobalData analysed the number of clinical trials examining checkpoint modulator trials with start dates between January 1, 2009 and October…
   Read More…

   22 Jan
2. Experts doubtful of Idorsia’s daridorexant uptake potential in insomnia

   Idorsia’s daridorexant has experts unsure of its uptake potential due to a lack of differentiation from an already approved insomnia therapy…
   Read More…

   17 Jan
3. Biogen’s aducanumab leans toward conditional versus full approval in Alzheimer’s

   Biogen’s aducanumab is more likely to be granted conditional versus full FDA approval in Alzheimer’s disease (AD) based on recently…
   Read More…

   17 Jan
4. Gene silencing therapy’s fast-track approval to expand treatment options for Huntington’s patients

   Globally, there are currently 24 products in clinical development for the treatment of Huntington’s disease, which is a rare, inheritable…
   Read More…

   9 Jan
5. Experts sceptical on Bristol-Myers Squibb’s head and neck cancer trial of Opdivo

   Bristol-Myers Squibb’s Phase III first-line head and neck squamous cell carcinoma (HNSCC) trial of Opdivo (nivolumab) and Yervoy (ipilimumab) has…
   Read More…

   7 Jan
6. UniQure’s etranacogene dezaparvovec in haemophilia B has experts positive on Phase III prospects

   UniQure’s AMT-061 (etranacogene dezaparvovec) in haemophilia B is expected to achieve clinically significant results in its Phase III HOPE-B trial,…
   Read More…

   7 Jan
7. iRhythm to participate in atrial fibrillation study to reduce stroke rates

   In December 2019, iRhythm announced that it is participating in the Guard-AF study by Bristol-Myers Squibb–Pfizer. The study aims to…
   Read More…

   3 Jan
8. BeiGene’s Phase III Trial of Zanubrutinib Misses Late-Stage Goals in Waldenström’s Macroglobulinemia

   Beigene announced that its Phase III Trial of zanubrutinib compared to Johnson & Johnson/AbbVie’s ibrutinib did not achieve statistical significance…
   Read More…

   2 Jan
9. Report raises doubts about influential clinical trial and heart disease guidelines

   On December 9th, BBC Newsnight came out with an investigation questioning the validity of the 2016 EXCEL clinical trial, led…
   Read More…

   2 Jan
10. Overview of industry-sponsored clinical trials in the UK, 2019

    GlobalData analysed the number of industry-sponsored clinical trials in the UK with a start date between 1 January 2019 and…
    Read More…

    23 Dec